Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 4 of 13 found articles
 
 
  Chimerism analysis following nonmyeloablative stem cell transplantation using a new cell subset separation method: Robosep™
 
 
Title: Chimerism analysis following nonmyeloablative stem cell transplantation using a new cell subset separation method: Robosep™
Author: Decot, V.
Latger-Cannard, V.
Lecompte, T.
Clément, L.
Salmon, A.
Bordigoni, P.
Stoltz, J.-F.
Bensoussan, D.
Appeared in: Bio-medical materials and engineering
Paging: Volume 18 (2008) nr. supplement-1 pages 19-26
Year: 2008-03-10
Contents: Chimerism analysis has become an important tool to manage patients in the peri-transplant period of allogenic stem cell transplantation. During this period, cells of donor and host origin can coexist and increasing proportion of cells of host origin is considered as a recurrence of the underlying disease. We currently performed chimerism analysis on separate peripheral blood cell subsets, lymphocytes and granulocytes. To improve our isolation method, a new automated device from Stem Cell Technology Robosep™ was tested and compared to our manual separation technique. The results obtained on T cell purification showed an improvement of the purity (98.42% with Robosep vs. 92.42% with the manual technique Rosettesep) and of the recovery (63.43% with Robosep and 38% with Rosettesep). The results were significantly improved on patient samples with less than 10% CD3 positive cells (purity: 90% vs. 44.44%; recovery: 73.79% vs. 43.98%). Granulocytes separation was based on CD15 expression. The results showed an improvement of the purity with Robosep (96.90% vs. 86.20% with the manual technique Polymorphprep) but the recovery was impaired (35.2% vs. 52.30%). Using a myeloid (CD66/CD33) cocktail, recovery was improved with the Robosep device (64.04% with the myeloid cocktail vs. 22.4% with the CD15 cocktail). Our data demonstrated that Robosep allowed a performant cell purification in the early period post-transplantation even for populations representing less than 10% of the peripheral blood cells.
Publisher: IOS Press
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 4 of 13 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands